Clinical trial
Clinical Efficacy of Stereotactic Radiotherapy and Microwave Ablation for Liver Metastases From Colorectal Cancer: a Prospective Multicenter Cohort Study
NCT03963726 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Efficacy of Stereotactic Radiotherapy and Microwave Ablation for Liver Metastases From Colorectal Cancer: a Prospective Multicenter Cohort Study
- Lead sponsor
- Peking University Third Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 3, 2019
- Completion date
- May 31, 2022
- Enrollment
- 100 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer, liver metastases, microwave ablation, radiotherapy